Navigation Links
New Transgenic Mushrooms Raise Hope for Mass Production of Human Drugs

Penn State and Agariger, Inc. have patented the technology of making new transgenic mushrooms, which have increased hope of using mushrooms for the mass production of commercially valuable proteins or useful human drugs.

The technology was introduced by a team of researchers including Charles Peter Romaine and Xi Chen at Penn State.

As part of the study, scientists developed a technique to genetically modify Agaricus bisporus, which is the predominant edible species worldwide by attaching a gene that confers resistance to hygromycin, an antibiotic, to circular pieces of bacterial DNA called plasmids, which have the ability to multiply within a bacterium known as Agrobacterium.

The hygromycin resistance gene was a marker gene to help sort out the transgenic mushroom cells from the non-transgenic cells.

Scientists then cut small pieces off the mushroom's gill tissue and added it to a flask containing the altered bacterium. Over the course of several days, as the bacterium went through its lifecycle, it transferred a portion of its plasmid into the mushroom cell, and integrated the introduced gene into the chromosome of the mushroom.

The researchers then exposed the mushroom cells to hygromycin. The antibiotic killed all the normal cells, separating out those that had been genetically altered for resistance.

The study demonstrated that if a second gene, insulin for example, were to be patched in the plasmid, that gene would be expressed as well.

"There is a high probability that if the mushroom cell has the hygromycin resistance gene, it will also have the partner gene," Romaine said.

Researchers noted that the process of producing biopharmaceuticals is potentially faster and cheaper with mushrooms than conventional technologies.

"With mushrooms, we can use commercial technology to convert the vegetative tissue from mushroom strains stored in t
'"/>




Page: 1 2

Related medicine news :

1. Goat’s Milk One of the First Transgenic Food That Benefits Human
2. Mushrooms can help fight chronic disease
3. Novel Vitamin D source in Mushrooms!
4. Mushrooms are Rich Source of Antioxidants
5. Four of Family Died After Consuming Poisonous Mushrooms
6. Magic Mushrooms Treat Obsessive Compulsion Disorder
7. Heavy Drinking Raises Risk of Liver Cancer
8. Swimming in Chlorinated Pools Raises Asthma Risk
9. New Treatment To Raise Good Cholesterol
10. Common Infections Found To Raise An Individuals Risk Of Having A Heart Attack Or Stroke
11. Polycystic Ovary In Women May Raise Liver Disease

Post Your Comments:
(Date:12/2/2009)... Experts outline practical approach to help org...ses to build business value and reduce costs. , ...mber 2, 2009 —- The pressure to comply with ... professionals than it is today. More than 75 perc...regulations and corresponding audits.¹ Withou...
(Date:12/2/2009)... ONDAMED® praised by Suzanne Somers in her ... Cornwall, NY (PRWEB) December 2, 2009...ors Who Are Curing Cancer, And How to Prevent Gett...ws doctors who are successfully using the most inn...p the body rather than tear it down. This is a sub...
(Date:12/2/2009)... eCube Systems Achieves IBM Ready for LINUX des...pplications to the mainframe and contemporary syst...ton, TX (PRWEB) December 2, 2009 -- eCube Systems,...rnization, today announced that it has achieved th...igh performance middleware. This mark certifies N...
(Date:12/2/2009)...ec. 2 Results of a larg...al meeting of the Radiological Society of North Am...the benefit of annual screening ultrasound for wom... breast cancer. In addition, the study confirmed t...ast cancer. ,, "We found that annual screening ...
(Date:12/2/2009)...TTLE, Dec. 2 Cell Therap...d today that Ruth Pettengell, M.D. of St. George,s...ator for the PIX 301 EXTEND trial will present new...d/refractory aggressive non-Hodgkin,s lymphoma (NH...ety of Hematology on Saturday, December 5, 2009 in...
Breaking Medicine News(10 mins):Health News:Lumension Webinar Discusses How to Effectively Streamline Security and Compliance Initiatives 2Health News:Lumension Webinar Discusses How to Effectively Streamline Security and Compliance Initiatives 3Health News:Innovative Biofeedback Technology Wins By A "Knockout." 2Health News:Innovative Biofeedback Technology Wins By A "Knockout." 3Health News:Innovative Biofeedback Technology Wins By A "Knockout." 4Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 2Health News:Annual Screening With Breast Ultrasound or MRI Could Benefit Some Women 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 2Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 3Health News:New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 4
... Delhi, Singapore and Washington DC (March 2, 2009...e recently asked to participate in a conference ca...ntial Transition Team. As a result, they were aske...n open letter to the president in the current issu...
...ction Health Care today announced that it is one o...ve accreditation by the Society of Chest Pain Cent...rs throughout the Chicago area, Resurrection physi... to ensure that a patient is neither sent home too...
...ds the Challenges to Working Families , , PITTSBU...heartily endorsed President Obama,s selection of G...of Health and Human Services (HHS). , , (Logo: h...f how intent the new Administration is on addressi...
...tor Designed for Ultra-High Performance Liquid Chr...o Launch New Coulometric UHPLC Cell , , CHELMSFO...lan Biosciences company and leader in novel HPLC s...ltra-high-performance version of its award-winning...
...ines proposed in the March 2009 issue of the journ...iversity School of Medicine and Riley Hospital for...atricians and family physicians treat non-active t...is growing number of children and save healthcare ...
... NanoBio Corp. announced today that it will prese...nd preclinical milestones in the development of it...ychomycosis and tinea capitis. The new data will b...to the oral poster presentations listed below, the...
Other Medicine News:Health News:AIDS care physicians make recommendations to Obama 2Health News:Resurrection Health Care Hospitals Receive Chest Pain Accreditation 2Health News:Steelworkers Say President's Choice for Health and Human Services a Good One 2Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 2Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 3Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 4Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 5Health News:Doctors call for change in how non-active TB in immigrant children treated 2Health News:NanoBio to Announce Key Clinical and Preclinical Data on Its Topical Anti-infective Lotions at AAD 2009 2
(Date:12/2/2009)...Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical..., a leading pharmaceutical company,specializing in...branded,generic and proprietary pharmaceuticals in... Yanshen Biological Technology Stock Co., Ltd. ("J...ts products in order to conduct an,internal inspec...
(Date:12/1/2009)... Reportlinker.com announces that a ...alogue: ,, Insulin Pumps (External) - A World ...p0164247/Insulin-Pumps-External---A-World-Market-R...nuous Subcutaneous Insulin Infusion (CSII), provid...ther forms of treatment. Insulin pump is a pager-s...
(Date:12/1/2009)...Dec. 1 drugstore.com, in...health, beauty, vision, and pharmacy products, tod...er as customer orders were the highest in company ...nd Beauty.com web stores featured more special o...t selection yet. ,, (Logo: http://www.newscom....
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Alzheimer 26apos 3Bs Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 61873 1Alzheimer 26apos 3Bs Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 61873 2Alzheimer 26apos 3Bs Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 61873 3MINDlink Foundation Launches to Connect the Cerebellum to Cures 61870 1MINDlink Foundation Launches to Connect the Cerebellum to Cures 61870 2U S Bishops Voice Disappointment in Abortion Funding Provisions in Senate Health Bill Urge Better Care for Immigrants and Affordability 61867 1U S Bishops Voice Disappointment in Abortion Funding Provisions in Senate Health Bill Urge Better Care for Immigrants and Affordability 61867 2
... ET Today, SOUTH SAN FRANCISCO, Calif., Jan. 14 ...d that the Independent Data,Monitoring Committee (...3,clinical trials of GVAX immunotherapy for prosta...lysis and has recommended that the study continue....o determine whether the,study should continue to c...
...tic,University and Scripps Florida will present th...nesday, January 16 from 4-5:30 p.m. in the,Univers...lobel, M.D., Ph.D.,is the 1999 recipient of the No.... Rockefeller, Jr. Professor, The Rockefeller Univ...stitute. He will present a lecture,entitled, "Nucl...
Other Medicine Technology:Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 2Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 3Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer 4Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University 2Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University 3
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: